- Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control
-
Buderath P, Rusch P, Mach P, Kimmig R
- KMID: 2526297
- J Gynecol Oncol.
- 2021 Jan;32(1):e7.
- doi: 10.3802/jgo.2021.32.e7
Objective: Peritoneal mesometrial resection (PMMR) plus targeted compartmental lymphadenectomy (TCL) aims at removal of the locoregional cancer field in endometrial cancer (EC). Optimal locoregional control without adjuvant radiotherapy and acceptable... -
- CITED
-
- Close
- SHARE
-
- Close
- Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study
-
Buderath P, Stukan M, Ruhwedel W, Strutas D, Feisel-Schwickardi G, Wimberger P, Kimmig R
- KMID: 2536012
- J Gynecol Oncol.
- 2022 Jan;33(1):e9.
- doi: 10.3802/jgo.2022.33.e9
Objective The surgical concept of total mesometrial resection (TMMR) and therapeutic lymphadenectomy (tLNE) for the treatment of early cervical cancer is based on the ontogenetic cancer field model. Unicentric data show... -
- CITED
-
- Close
- SHARE
-
- Close
- Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part)
-
Kimmig R, Buderath P, Rusch P, Mach P, Aktas B
- KMID: 2413228
- J Gynecol Oncol.
- 2017 Sep;28(5):e68.
- doi: 10.3802/jgo.2017.28.e68
OBJECTIVE: Para-aortic indocyanine-green (ICG)-guided targeted compartmental lymphadenectomy is feasible in early ovarian cancer; systematic pelvic and para-aortic lymphadenectomy could potentially be avoided if thoroughly investigated sentinel nodes could predict whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical treatment of early ovarian cancer with compartmental resection of regional lymphatic network and indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, paraaortic part)
-
Kimmig R, Buderath P, Mach P, Rusch P, Aktas B
- KMID: 2413449
- J Gynecol Oncol.
- 2017 May;28(3):e41.
- doi: 10.3802/jgo.2017.28.e41
OBJECTIVE: Whether pelvic and para-aortic lymphadenectomy is of therapeutic benefit in advanced ovarian cancer will remain unclear until the publication of the Arbeitsgemeinschaft Gynäkologische Onkologie lymphadenectomy in ovarian neoplasms (AGO... -
- CITED
-
- Close
- SHARE
-
- Close
